We are part of the CSL Limited group of companies. See how we're Driven by Our Promise.
We collaborate with rare disease organizations to promote quality medical care and services.
We offer a variety of support programs and activities for the patients we serve.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
We work every day as if someone’s life depends on it, because it does.
We manufacture products to treat a number of rare diseases.
Help us deliver on our promise to save lives and protect the health of people.
Diversity and inclusion are top priorities for CSL Behring.
Science Emoji and the Pandemic
Because of COVID-19, for the first time, the microbe emoji soared in popularity and in March featured in one out of every 50…
Nominations for 2021 Young Investigator Draft
Uplifting Athletes event offers $20,000 grants for rare disease researchers.
Take a Virtual Lab Tour
Go behind the scenes in Marburg, Germany, to learn how scientists remove pathogens from medicines to make them safe for patie…
Supporting Top Talent in Germany
CSL Behring provides 14 scholarships to several schools, including a partner university of Penn State.
Explainer: What Is Albumin?
Get five fast facts about albumin and its role in treating serious medical conditions.
Soap Can Kill the Virus That Causes COVID-19
CSL Behring scientists in Germany discovered that sodium laureth sulfate – found in many liquid soaps – works on various surf…
Celebrating Nobel Week
Learn 7 facts about Emil von Behring, winner of the first Nobel Prize for medicine.
No Stopping STEM
CSL Behring employees help a Philadelphia-area mentorship program zoom along during pandemic.
Expansion Nears Completion in Switzerland
CSL Behring validates new production capacity in Bern.
Harnessing the 'Spirit of Innovation'
CSL Behring opens its first Philadelphia lab at University City Science Center.
Accessing Early Innovation in Europe
Research initiative connects CSL Behring with early-stage biotech ventures.
Machine Learning and a Slippery Prognosis
A Google subsidiary invites data scientists to crowd-solve big problems, like predicting lung function decline in patients wi…
Popular search terms:
Americas
Asia Pacific
Europe
This website uses cookies to improve user experience. By continuing to use this website, you consent to our use of these cookies. To learn more about how we use and manage cookies, see our Privacy Policy and Cookie Policy.
